The Role of Osteoclast Energy Metabolism in the Occurrence and Development of Osteoporosis
Open accessThe DOI matches its Crossref record; 170 of the 170 references it cites were found in a registry or an index.
Abstract
In recent decades, the mechanism underlying bone metabolic disorders based on energy metabolism has been heavily researched. Bone resorption by osteoclasts plays an important role in the occurrence and development of osteoporosis. However, the mechanism underlying the osteoclast energy metabolism disorder that interferes with bone homeostasis has not been determined. Bone resorption by osteoclasts is a process that consumes large amounts of adenosine triphosphate (ATP) produced by glycolysis and oxidative phosphorylation. In addition to glucose, fatty acids and amino acids can also be used as substrates to produce energy through oxidative phosphorylation. In this review, we summarize and analyze the energy-based phenotypic changes, epigenetic regulation, and coupling with systemic energy metabolism of osteoclasts during the development and progression of osteoporosis. At the same time, we propose a hypothesis, the compensatory recovery mechanism (involving the balance between osteoclast survival and functional activation), which may provide a new approach for the treatment of osteoporosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Mitochondrial Autophagy Is an HIF-1-dependent Adaptive Metabolic Response to Hypoxia
Zhang, H., Bosch-Marce, M., Shimoda, L. A., Tan, Y. S., Baek, J. H., Wesley, J. B., Gonzalez, F. J., & Semenza, G. L. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800102200 · Cited by 1,601 · cited 1×
“At the same time, HIF induces the expression of BCL-2 interacting protein 3 (BNIP3) to compete with beclin-1 for binding to BCL-2, resulting in the release of beclin-1 to stimulate mitochondrial autophagy and a decrease in ROS accumulation (108).”
BackgroundRetractedAMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1α
Jäger, S., Handschin, C., St.-Pierre, J., & Spiegelman, B. M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705070104 · Cited by 2,491
Gao, P., Tchernyshyov, I., Chang, T.-C., Lee, Y.-S., Kita, K., Ochi, T., Zeller, K. I., De Marzo, A. M., Van Eyk, J. E., Mendell, J. T., et al. (2009) · Nature · doi:10.1038/nature07823 · Cited by 2,124 · cited 1×
“The expression of Na-dependent glutamine neutral amino acid transporter B (0) increases during differentiation and plays an important role in later differentiation stages (39, 120).”
BackgroundGenetic regulation of osteoclast development and function
Teitelbaum, S. L., & Ross, F. P. (2003) · Nature Reviews Genetics · doi:10.1038/nrg1122 · Cited by 1,701 · cited 1×
“Local acidosis in the absorption chamber erodes inorganic minerals, leading to the exposure of the organic collagen matrix to proteolytic enzymes, including collagenase, cathepsin K (CTSK) and matrix metalloproteinases (MMPs) (34, 35).”
BackgroundAdvanced Glycation End Products and Diabetic Complications
Singh, V. P., Bali, A., Singh, N., & Jaggi, A. S. (2014) · The Korean Journal of Physiology & Pharmacology · doi:10.4196/kjpp.2014.18.1.1 · Cited by 1,518
Weaver, C. M., Gordon, C. M., Janz, K. F., Kalkwarf, H. J., Lappe, J. M., Lewis, R., O’Karma, M., Wallace, T. C., & Zemel, B. S. (2016) · Osteoporosis International · doi:10.1007/s00198-015-3440-3 · Cited by 1,378
Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism
Ferron, M., Wei, J., Yoshizawa, T., Del Fattore, A., DePinho, R. A., Teti, A., Ducy, P., & Karsenty, G. (2010) · Cell · doi:10.1016/j.cell.2010.06.003 · Cited by 1,123
Adiponectin and AdipoR1 Regulate PGC-1α and Mitochondria by Ca2+ and AMPK/SIRT1
Iwabu, M., Yamauchi, T., Okada-Iwabu, M., Sato, K., Nakagawa, T., Funata, M., Yamaguchi, M., Namiki, S., Nakayama, R., Tabata, M., et al. (2010) · Nature · doi:10.1038/nature08991 · Cited by 971
A crucial role for reactive oxygen species in RANKL-induced osteoclast differentiation
Lee, N. K., Choi, Y. G., Baik, J. Y., Han, S. Y., Jeong, D.-W., Bae, Y. S., Kim, N., & Lee, S. Y. (2005) · Blood · doi:10.1182/blood-2004-09-3662 · Cited by 957
Activation of the NADPH oxidase involves the small GTP-binding protein p21rac1
Abo, A., Pick, E., Hall, A., Totty, N., Teahan, C. G., & Segal, A. W. (1991) · Nature · doi:10.1038/353668a0 · Cited by 954 · cited 1×
“Alternatively, ROS are also produced by the activation of NADPH oxidase (NOX2) in the cytosol (109).”
BackgroundShort-chain fatty acids regulate systemic bone mass and protect from pathological bone loss
Lucas, S., Omata, Y., Hofmann, J., Böttcher, M., Iljazovic, A., Sarter, K., Albrecht, O., Schulz, O., Krishnacoumar, B., Krönke, G., et al. (2018) · Nature Communications · doi:10.1038/s41467-017-02490-4 · Cited by 815 · cited 1×
“Short-chain fatty acids (SCFAs) inhibit osteoclast production in vivo and in vitro (128).”
BackgroundMechanisms of Bone Resorption in Periodontitis
Hienz, S. A., Paliwal, S., & Ivanovski, S. (2015) · Journal of Immunology Research · doi:10.1155/2015/615486 · Cited by 762
Oxidative stress in bone remodeling: role of antioxidants
Domazetovic, V (2017) · Clinical Cases in Mineral and Bone Metabolism · doi:10.11138/ccmbm/2017.14.1.209 · Cited by 758
Glatz, J. F. C., Luiken, J. J. F. P., & Bonen, A. (2010) · Physiological Reviews · doi:10.1152/physrev.00003.2009 · Cited by 751
Frattini, A., Orchard, P. J., Sobacchi, C., Giliani, S., Abinun, M., Mattsson, J. P., Keeling, D. J., Andersson, A.-K., Wallbrandt, P., Zecca, L., et al. (2000) · Nature Genetics · doi:10.1038/77131 · Cited by 674
Lee, S.-H., Rho, J., Jeong, D., Sul, J.-Y., Kim, T., Kim, N., Kang, J.-S., Miyamoto, T., Suda, T., Lee, S.-K., et al. (2006) · Nature Medicine · doi:10.1038/nm1514 · Cited by 546
Oxygen-dependent regulation of mitochondrial respiration by hypoxia-inducible factor 1
Semenza, G. L. (2007) · Biochemical Journal · doi:10.1042/bj20070389 · Cited by 541 · cited 1×
“In general, cellular adaptation to hypoxia usually requires switching to anaerobic metabolism, reducing the production of ATP to prevent the accumulation of reactive oxygen species (107).”
BackgroundPPAR-γ regulates osteoclastogenesis in mice
Wan, Y., Chong, L.-W., & Evans, R. M. (2007) · Nature Medicine · doi:10.1038/nm1672 · Cited by 517
Agidigbi, T. S., & Kim, C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20143576 · Cited by 511 · cited 1×
“Regardless of the source of ROS, studies have shown that excessively elevated ROS levels weaken the differentiation and function of osteoclasts and help to limit bone resorption (70, 88, 112).”
BackgroundAutophagy Proteins Regulate the Secretory Component of Osteoclastic Bone Resorption
DeSelm, C. J., Miller, B. C., Zou, W., Beatty, W. L., van Meel, E., Takahata, Y., Klumperman, J., Tooze, S. A., Teitelbaum, S. L., & Virgin, H. W. (2011) · Developmental Cell · doi:10.1016/j.devcel.2011.08.016 · Cited by 487 · cited 3×
“Selective deletion of autophagyrelated protein 7 (ATG7) in monocytes reduces osteoclast differentiation and bone loss induced by glucocorticoids and oophorectomy, and the deletion of ATG5 in osteoclasts also reduces bone loss caused by estrogen deficiency (75, 76).”
BackgroundTai, E. S., Tan, M. L. S., Stevens, R. D., Low, Y. L., Muehlbauer, M. J., Goh, D. L. M., Ilkayeva, O. R., Wenner, B. R., Bain, J. R., Lee, J. J. M., et al. (2010) · Diabetologia · doi:10.1007/s00125-009-1637-8 · Cited by 471
Energy Metabolism of the Osteoblast: Implications for Osteoporosis
Lee, W.-C., Guntur, A. R., Long, F., & Rosen, C. J. (2017) · Endocrine Reviews · doi:10.1210/er.2017-00064 · Cited by 443
Wu, Y., Xie, L., Wang, M., Xiong, Q., Guo, Y., Liang, Y., Li, J., Sheng, R., Deng, P., Wang, Y., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06898-4 · Cited by 430 · cited 2×
“The balance of osteogenic and lipogenic differentiation of bone marrow mesenchymal stem cells controls the osteoblasts involved in the formation of new bone mass (3).”
BackgroundCoordination of PGC-1β and iron uptake in mitochondrial biogenesis and osteoclast activation
Ishii, K.-A., Fumoto, T., Iwai, K., Takeshita, S., Ito, M., Shimohata, N., Aburatani, H., Taketani, S., Lelliott, C. J., Vidal-Puig, A., et al. (2009) · Nature Medicine · doi:10.1038/nm.1910 · Cited by 410 · cited 1×
“Moreover, the increased intake of iron through upregulated transferrin receptor protein 1 (TFR1) induces mitochondrial respiration to ensure a sufficient energy supply, and increased production of reactive oxygen species (ROS) through an NADPH oxidase (nicotinamide adenine dinucleotide phosphate oxidase)-dependent pro…”
BackgroundRecent advances in osteoclast biology
Ono, T., & Nakashima, T. (2018) · Histochemistry and Cell Biology · doi:10.1007/s00418-018-1636-2 · Cited by 384 · cited 1×
“Osteoclasts involved in bone resorption are derived from monocyte/macrophage lineage cells, which are fused to form multicellular giant cells that are capable of bone resorption (4).”
BackgroundObesity, osteoporosis and bone metabolism.
Gkastaris, K., Goulis, D. G., Potoupnis, M. E., Anastasilakis, A. D., & Kapetanos, G. (2020) · PubMed Central · Cited by 371
Functional inactivation of the IGF-I and insulin receptors in skeletal muscle causes type 2 diabetes
Fernández, A. M., Kim, J. K., Yakar, S., Dupont, J., Hernandez-Sanchez, C., Castle, A. L., Filmore, J., Shulman, G. I., & Le Roith, D. (2001) · Genes & Development · doi:10.1101/gad.908001 · Cited by 369
Hypoxia is a major stimulator of osteoclast formation and bone resorption
Arnett, T. R., Gibbons, D. C., Utting, J. C., Orriss, I. R., Hoebertz, A., Rosendaal, M., & Meghji, S. (2003) · Journal of Cellular Physiology · doi:10.1002/jcp.10321 · Cited by 323 · cited 1×
“Hypoxia also regulates the occurrence of osteoclast apoptosis, which reduces the viability of mature osteoclasts (62, 63).”
BackgroundChow, D. C., Wenning, L. A., Miller, W. M., & Papoutsakis, E. T. (2001) · Biophysical Journal · doi:10.1016/s0006-3495(01)75733-5 · Cited by 317
Rosiglitazone Induces Decreases in Bone Mass and Strength that Are Reminiscent of Aged Bone
Lazarenko, O. P., Rzonca, S. O., Hogue, W. R., Swain, F. L., Suva, L. J., & Lecka-Czernik, B. (2007) · Endocrinology · doi:10.1210/en.2006-1587 · Cited by 302
Jin, Z., Wei, W., Yang, M., Du, Y., & Wan, Y. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.07.011 · Cited by 283 · cited 1×
“Moreover, in a model of inflammatory bone loss induced by lipopolysaccharide (LPS), NDUFS4 knockout restores bone mass, suggesting that mitochondrial complex I inhibition may provide a therapeutic direction based on the energy required for inflammatory osteoporosis (54).”
BackgroundMechanism of Bone Mineralization
Murshed, M. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a031229 · Cited by 280 · cited 1×
“Bone is composed of minerals such as calcium phosphate and calcium carbonate calcium citrate, as well as organic ingredients such as collagen matrix (30).”
BackgroundThyroid diseases and bone health
Williams, G. R., & Bassett, J. H. D. (2018) · Journal of Endocrinological Investigation · doi:10.1007/s40618-017-0753-4 · Cited by 276 · cited 1×
“The imbalance between bone resorption and bone formation shortens the bone remodeling cycle, resulting in a net loss of bone in each remodeling cycle, which accelerates the occurrence and development of osteoporosis (131, 132).”
BackgroundThe Functional Impact of Mitochondrial Structure Across Subcellular Scales
Glancy, B., Kim, Y., Katti, P., & Willingham, T. B. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.541040 · Cited by 265 · cited 1×
“Mitochondria are the key organelles for energy metabolism, and their outer membrane contains porins with high permeability; the inner membrane is highly opaque and folds inward to form cristae containing energy conversion-related proteins (electron transport chain, ATP synthase, and endometrial transport protein) (24,…”
BackgroundArnett, T. R. (2010) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2010.07.021 · Cited by 265 · cited 1×
“Notably, hypoxia reduced the viability of mature osteoclasts, thus suggesting that OXPHOS promotes osteoclast survival (67).”
BackgroundGlucocorticoids and bone: consequences of endogenous and exogenous excess and replacement therapy
Hardy, R. S., Zhou, H., Seibel, M. J., & Cooper, M. S. (2018) · Endocrine Reviews · doi:10.1210/er.2018-00097 · Cited by 258
Osteoporosis: Pathophysiology and therapeutic options
Föger‐Samwald, U., Dovjak, P., Azizi-Semrad, U., Kerschan‐Schindl, K., & Pietschmann, P. (2020) · EXCLI journal · doi:10.17179/excli2020-2591 · Cited by 257
mTOR signaling in skeletal development and disease
Chen, J., & Long, F. (2018) · Bone Research · doi:10.1038/s41413-017-0004-5 · Cited by 254 · cited 1×
“In addition, activated AMPK promotes osteoclast autophagy and increases osteoclast differentiation and bone resorption by inactivating mammalian target of rapamycin (mTOR) under lowenergy conditions, such as glucose or aminoaciddeficiency (82, 83).”
BackgroundGlutamine Metabolism Regulates Proliferation and Lineage Allocation in Skeletal Stem Cells
Yu, Y., Newman, H., Shen, L., Sharma, D., Hu, G., Mirando, A. J., Zhang, H., Knudsen, E., Zhang, G.-F., Hilton, M. J., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.01.016 · Cited by 253 · cited 1×
“Glutamine is decomposed to form a-ketoglutarate, which enters the tricarboxylic acid cycle and is converted to citrate through oxidation (118, 119).”
BackgroundPGC1β Mediates PPARγ Activation of Osteoclastogenesis and Rosiglitazone-Induced Bone Loss
Wei, W., Wang, X., Yang, M., Smith, L. C., Dechow, P. C., & Wan, Y. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.04.015 · Cited by 243
Autophagy in bone homeostasis and the onset of osteoporosis
Yin, X., Zhou, C., Li, J., Liu, R., Shi, B., Yuan, Q., & Zou, S. (2019) · Bone Research · doi:10.1038/s41413-019-0058-7 · Cited by 235 · cited 1×
“A disorder in the energy metabolism of osteoclasts leads to disruptions in autophagy activity and the balance between bone formation and bone resorption and mediates the occurrence and progression of a variety of bone diseases, including osteoporosis (87, 88).”
BackgroundMetabolic regulation of osteoclast differentiation and function
Indo, Y., Takeshita, S., Ishii, K.-A., Hoshii, T., Aburatani, H., Hirao, A., & Ikeda, K. (2013) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1976 · Cited by 233 · cited 5×
“, hexokinase, phosphofructokinase and pyruvate kinase (38, 40)], TCA cycle and OXPHOS, which indicates increased energy production (31).”
BackgroundInfluentialNishikawa, K., Iwamoto, Y., Kobayashi, Y., Katsuoka, F., Kawaguchi, S.-I., Tsujita, T., Nakamura, T., Kato, S., Yamamoto, M., Takayanagi, H., et al. (2015) · Nature Medicine · doi:10.1038/nm.3774 · Cited by 226
Gil-Henn, H., Destaing, O., Sims, N. A., Aoki, K., Alles, N., Neff, L., Sanjay, A., Bruzzaniti, A., De Camilli, P., Baron, R., et al. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200701148 · Cited by 226 · cited 1×
“Apyrase treatment or P2RX7 ablation reverses this inhibition (29, 106).”
BackgroundEnergy metabolism in osteoclast formation and activity
Lemma, S., Sboarina, M., Porporato, P. E., Zini, N., Sonveaux, P., Di Pompo, G., Baldini, N., & Avnet, S. (2016) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2016.08.034 · Cited by 222 · cited 3×
“The energy required for osteoclast differentiation is mainly derived from mitochondrial oxidative metabolism (increased expression of OXPHOS enzymes, complexes I, II, III and V, electron transport chain subunits, intracellular ATP levels and a higher oxygen consumption rate) (89), while the activity of peripheral cell…”
BackgroundThyroid Hormone Diseases and Osteoporosis
Delitala, A. P., Scuteri, A., & Doria, C. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9041034 · Cited by 220 · cited 1×
“The imbalance between bone resorption and bone formation shortens the bone remodeling cycle, resulting in a net loss of bone in each remodeling cycle, which accelerates the occurrence and development of osteoporosis (131, 132).”
BackgroundHow the osteoclast degrades bone
Blair, H. C. (1998) · BioEssays · doi:10.1002/(sici)1521-1878(199810)20:10<837::aid-bies9>3.0.co;2-d · Cited by 219 · cited 1×
“Afterwards, mature osteoclasts adhere to the bone surface through avb integrin and form an F-actinsealed zone to absorb the bone matrix, while the acidic environment in the bone resorption region relies on carbonic anhydrase II to generate HCO and H, which passes through the folds of osteoclasts through vacuolar H ade…”
BackgroundRole of Lipids in Osteoporosis
Parhami, F., Garfinkel, A., & Demer, L. L. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.11.2346 · Cited by 205
Hyperlipidemia Promotes Osteoclastic Potential of Bone Marrow Cells Ex Vivo
Tintut, Y., Morony, S., & Demer, L. L. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000112023.62695.7f · Cited by 202
Metabolic reprogramming in osteoclasts
Park-Min, K.-H. (2019) · Seminars in Immunopathology · doi:10.1007/s00281-019-00757-0 · Cited by 191 · cited 1×
“Propionate (C3) and butyrate (C4) cause metabolic reprogramming (conversion of oxidative phosphorylation to glycolysis) in osteoclasts and downregulate TNF receptor associated factor 6 (TRAF6) and NFATc1, leading to a decrease in osteoclastogenesis that may depend on oxidative stress and acid accumulation, and treatme…”
BackgroundA RANKL–PKCβ–TFEB signaling cascade is necessary for lysosomal biogenesis in osteoclasts
Ferron, M., Settembre, C., Shimazu, J., Lacombe, J., Kato, S., Rawlings, D. J., Ballabio, A., & Karsenty, G. (2013) · Genes & Development · doi:10.1101/gad.213827.113 · Cited by 182 · cited 1×
“In mice with an osteoclastspecific TFEB deficiency, the decrease in lysosomes was accompanied by a decrease in lysosomal gene expression and a decrease in theboneabsorptive capacity (79, 80).”
BackgroundCejka, D., Hayer, S., Niederreiter, B., Sieghart, W., Fuereder, T., Zwerina, J., & Schett, G. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27504 · Cited by 174 · cited 1×
“This inhibitory effect enhances autophagy, which increases the bone resorption capacity by regulating actin and the microtubule network (75, 85); however, the inhibition of mTOR downregulates the expression of digestive enzymes and induces osteoclast apoptosis (86).”
BackgroundWhere Metabolism Meets Senescence: Focus on Endothelial Cells
Sabbatinelli, J., Prattichizzo, F., Olivieri, F., Procopio, A. D., Rippo, M. R., & Giuliani, A. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.01523 · Cited by 167
High d(+)glucose concentration inhibits RANKL-induced osteoclastogenesis
Wittrant, Y., Gorin, Y., Woodruff, K., Horn, D., Abboud, H. E., Mohan, S., & Abboud-Werner, S. L. (2008) · Bone · doi:10.1016/j.bone.2008.02.006 · Cited by 164
AMP kinase acts as a negative regulator of RANKL in the differentiation of osteoclasts
Lee, Y., Kim, Y.-S., Lee, S.-Y., Kim, G.-H., Kim, B., Lee, S., Lee, K., Kim, G.-S., Kim, S., & Koh, J. (2010) · Bone · doi:10.1016/j.bone.2010.08.001 · Cited by 164 · cited 1×
“Reduced intracellular ratios of ATP : ADP or ATP: AMP activate AMPK and inhibit osteoclast differentiation and function (99).”
BackgroundRedox Regulation by Thioredoxin and Thioredoxin‐Binding Proteins
Nishiyama, A., Masutani, H., Nakamura, H., Nishinaka, Y., & Yodoi, J. (2001) · IUBMB Life · doi:10.1080/15216540252774739 · Cited by 163 · cited 1×
“Thioredoxin will be released as an antioxidant under oxidative stress conditions (113).”
BackgroundClinical Impact and Cellular Mechanisms of Iron Overload-Associated Bone Loss
Jeney, V. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00077 · Cited by 163
Karner, C. M., & Long, F. (2018) · Bone · doi:10.1016/j.bone.2017.08.008 · Cited by 163 · cited 2×
“In some cases, glucose is converted to lactate under aerobic conditions through a process known as aerobic glycolysis (also known as the Warburg effect) (20).”
BackgroundMartina, J. A., Diab, H. I., Li, H., & Puertollano, R. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1565-8 · Cited by 158 · cited 1×
“In mice with an osteoclastspecific TFEB deficiency, the decrease in lysosomes was accompanied by a decrease in lysosomal gene expression and a decrease in theboneabsorptive capacity (79, 80).”
BackgroundModel‐driven multi‐omic data analysis elucidates metabolic immunomodulators of macrophage activation
Bordbar, A., Mo, M. L., Nakayasu, E. S., Schrimpe‐Rutledge, A. C., Kim, Y., Metz, T. O., Jones, M. B., Frank, B. C., Smith, R. D., Peterson, S. N., et al. (2012) · Molecular Systems Biology · doi:10.1038/msb.2012.21 · Cited by 157 · cited 1×
“Intracellular proteins involved in lysine degradation are enriched during osteoclasts, and the biosynthesis of tyrosine, phenylalanine, and tryptophan is activated (37, 123).”
BackgroundThe role of osteoclast differentiation and function in skeletal homeostasis
Ikeda, K., & Takeshita, S. (2016) · Journal of Biochemistry · doi:10.1093/jb/mvv112 · Cited by 154 · cited 1×
“, hexokinase, phosphofructokinase and pyruvate kinase (38, 40)], TCA cycle and OXPHOS, which indicates increased energy production (31).”
BackgroundCellular and mitochondrial mechanisms of atrial fibrillation
Mason, F. E., Pronto, J. R. D., Alhussini, K., Maack, C., & Voigt, N. (2020) · Basic Research in Cardiology · doi:10.1007/s00395-020-00827-7 · Cited by 154
Hypoxia stimulates vesicular ATP release from rat osteoblasts
Orriss, I. R., Knight, G. E., Utting, J. C., Taylor, S. E. B., Burnstock, G., & Arnett, T. R. (2009) · Journal of Cellular Physiology · doi:10.1002/jcp.21745 · Cited by 153 · cited 1×
“Osteoblasts release a large amount of ATP through vesicle-mediated exocytosis, resulting in a significant increase in the extracellular concentration of adenosine during hypoxia or inflammation (100, 101).”
BackgroundNew regulation mechanisms of osteoclast differentiation
Nakashima, T., & Takayanagi, H. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06373.x · Cited by 152 · cited 1×
“Meanwhile, the production of oxygen free radicals in mitochondria is closely related to cellular signal transduction, transmembrane ion transport and electrolyte homeostasis (26, 27).”
BackgroundUnderstanding the local actions of lipids in bone physiology
During, A., Penel, G., & Hardouin, P. (2015) · Progress in Lipid Research · doi:10.1016/j.plipres.2015.06.002 · Cited by 150
SOD2 and Sirt3 Control Osteoclastogenesis by Regulating Mitochondrial ROS
Kim, H., Lee, Y. D., Kim, H. J., Lee, Z. H., & Kim, H.-H. (2017) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2974 · Cited by 148
The many ways of osteoclast activation
Lorenzo, J. (2017) · Journal of Clinical Investigation · doi:10.1172/jci94606 · Cited by 142 · cited 1×
“consumption, ATP production, and respiratory capacity and reserve) of osteoclasts induced by RANKL depends on MYC/ ERRa, and NFATc1-independent pathways downstream of MYC mediate the ability of RANKL/RANK signaling to influence osteoclasts (55, 56).”
BackgroundMiyazaki, T., Iwasawa, M., Nakashima, T., Mori, S., Shigemoto, K., Nakamura, H., Katagiri, H., Takayanagi, H., & Tanaka, S. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.385369 · Cited by 142
ATP is a potent stimulator of the activation and formation of rodent osteoclasts
Morrison, M. S., Turin, L., King, B. F., Burnstock, G., & Arnett, T. R. (1998) · The Journal of Physiology · doi:10.1111/j.1469-7793.1998.495bh.x · Cited by 141 · cited 1×
“However, high concentrations of ATP inhibit osteoclast formation and activity (61).”
BackgroundKim, J.-M., Jeong, D., Kang, H. K., Jung, S. Y., Kang, S. S., & Min, B.-M. (2007) · Cellular Physiology and Biochemistry · doi:10.1159/000110454 · Cited by 137 · cited 3×
“In contrast, hyperglycemia (40 mM) inhibits RANKL-induced osteoclast formation (31, 142), which can be explained by metabolic effects such as a lower oxygen consumption rate at higher glucose levels (143).”
BackgroundTherapeutic potentials and modulatory mechanisms of fatty acids in bone
Bao, M., Zhang, K., Wei, Y., Hua, W., Gao, Y., Li, X., & Ye, L. (2019) · Cell Proliferation · doi:10.1111/cpr.12735 · Cited by 135
Mitochondrial Regulation of Stem Cells in Bone Homeostasis
Zheng, C., Sui, B., Qiu, X., Hu, C., & Jin, Y. J. (2019) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2019.04.008 · Cited by 129 · cited 1×
“The effect of OXPHOS on osteoclast formation can be further inhibited by the respiratory chain disruptor rotenone, thereby eliminating bone loss due to estrogen deficiency in mice (57, 58).”
BackgroundModulation of Osteoclastogenesis by Fatty Acids
Cornish, J., MacGibbon, A., Lin, J.-M., Watson, M., Callon, K. E., Tong, P. C., Dunford, J. E., van der Does, Y., Williams, G. A., Grey, A. B., et al. (2008) · Endocrinology · doi:10.1210/en.2008-0111 · Cited by 128
Heme oxygenase 1 (HO‐1) regulates osteoclastogenesis and bone resorption
Zwerina, J., Tzima, S., Hayer, S., Redlich, K., Hoffmann, O., Hanslik‐Schnabel, B., Smolen, J. S., Kollias, G., & Schett, G. (2005) · The FASEB Journal · doi:10.1096/fj.05-4278fje · Cited by 127
Schirrmacher, V. (2020) · Biomedicines · doi:10.3390/biomedicines8110526 · Cited by 124
Disorders of branched chain amino acid metabolism
Manoli, I., & Venditti, C. P. (2016) · Translational Science of Rare Diseases · doi:10.3233/trd-160009 · Cited by 124 · cited 1×
“In addition, the essential amino acids required for osteoclastogenesis, including a-ketoisocaproate, ketoisoleucine and phenylpyruvate, are the intermediate metabolites of leucine, isoleucine and phenylalanine, respectively, and those metabolites regulate the ATP supply through acetyl-CoA entry into the TCA cycle (121…”
BackgroundInactivation of autophagy ameliorates glucocorticoid-induced and ovariectomy-induced bone loss
Lin, N.-Y., Chen, C.-W., Kagwiria, R., Liang, R., Beyer, C., Distler, A., Luther, J., Engelke, K., Schett, G., & Distler, J. H. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2015-207240 · Cited by 123 · cited 1×
“Selective deletion of autophagyrelated protein 7 (ATG7) in monocytes reduces osteoclast differentiation and bone loss induced by glucocorticoids and oophorectomy, and the deletion of ATG5 in osteoclasts also reduces bone loss caused by estrogen deficiency (75, 76).”
BackgroundLong-Chain Polyunsaturated Fatty Acids and the Regulation of Bone Metabolism
Poulsen, R. C., Moughan, P. J., & Kruger, M. C. (2007) · Experimental Biology and Medicine · doi:10.3181/0704-mr-100 · Cited by 120
SIRT1 is a positive regulator of in vivo bone mass and a therapeutic target for osteoporosis
Zainabadi, K., Liu, C. J., Caldwell, A. L. M., & Guarente, L. (2017) · PLoS ONE · doi:10.1371/journal.pone.0185236 · Cited by 119
MYC-dependent oxidative metabolism regulates osteoclastogenesis via nuclear receptor ERRα
Bae, S., Lee, M. J., Mun, S. H., Giannopoulou, E. G., Yong-Gonzalez, V., Cross, J. R., Murata, K., Giguère, V., van der Meulen, M., & Park-Min, K.-H. (2017) · Journal of Clinical Investigation · doi:10.1172/jci89935 · Cited by 119 · cited 3×
“consumption, ATP production, and respiratory capacity and reserve) of osteoclasts induced by RANKL depends on MYC/ ERRa, and NFATc1-independent pathways downstream of MYC mediate the ability of RANKL/RANK signaling to influence osteoclasts (55, 56).”
BackgroundHow to manage osteoporosis before the age of 50.
Rozenberg, S., Bruyère, O., Bergmann, P., Cavalier, E., Gielen, E., Goemaere, S., Kaufman, J. M., Lapauw, B., Laurent, M. R., De Schepper, J., et al. (2020) · Maturitas · doi:10.1016/j.maturitas.2020.05.004 · Cited by 118
Succinate and its G-protein-coupled receptor stimulates osteoclastogenesis
Guo, Y., Xie, C., Li, X., Yang, J., Yu, T., Zhang, R., Zhang, T., Saxena, D., Snyder, M., Wu, Y., et al. (2017) · Nature Communications · doi:10.1038/ncomms15621 · Cited by 117
Acute hypoxia and osteoclast activity: a balance between enhanced resorption and increased apoptosis
Knowles, H. J., & Athanasou, N. A. (2009) · The Journal of Pathology · doi:10.1002/path.2534 · Cited by 116
Metabolic properties of the osteoclast
Arnett, T. R., & Orriss, I. R. (2017) · Bone · doi:10.1016/j.bone.2017.12.021 · Cited by 116 · cited 3×
“The expression of Na-dependent glutamine neutral amino acid transporter B (0) increases during differentiation and plays an important role in later differentiation stages (39, 120).”
BackgroundAutophagy and Energy Metabolism
Yang, J., Zhou, R., & Ma, Z. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-0602-4_16 · Cited by 115 · cited 1×
“Autophagy is a dynamic process that is the key and fine-tuning process for maintaining energy homeostasis (73).”
BackgroundFaje, A. T., Karim, L., Taylor, A., Lee, H., Miller, K. K., Mendes, N., Meenaghan, E., Goldstein, M. A., Bouxsein, M. L., Misra, M., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-4153 · Cited by 114
NADPH oxidases in bone homeostasis and osteoporosis
Schröder, K. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.08.036 · Cited by 114
Hypoxia-inducible factor regulates osteoclast-mediated bone resorption: role of angiopoietin-like 4
Knowles, H. J., Cleton-Jansen, A.-M., Korsching, E., & Athanasou, N. A. (2010) · The FASEB Journal · doi:10.1096/fj.10-162230 · Cited by 113
Molecular regulatory mechanisms of osteoclastogenesis through cytoprotective enzymes
Kanzaki, H., Shinohara, F., Kanako, I., Yamaguchi, Y., Fukaya, S., Miyamoto, Y., Wada, S., & Nakamura, Y. (2016) · Redox Biology · doi:10.1016/j.redox.2016.01.006 · Cited by 111
Regulation of Osteoclastic Bone Resorption by Glucose
Williams, J. P., Blair, H. C., McDonald, J. M., McKenna, M. A., Jordan, S. E., Williford, J., & Hardy, R. W. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6795 · Cited by 109
Saturated fatty acids enhance osteoclast survival
Oh, S., Sul, O., Kim, Y. Y., Kim, H. J., Yu, R., Suh, J. H., & Choi, H. (2009) · Journal of Lipid Research · doi:10.1194/jlr.m800626 · Cited by 109
Kim, H., Ponte, F., Nookaew, I., Ucer, S., Carvalho, A. L., Iyer, S. V., Warren, A. D., Aykin‐Burns, N., Krager, K. J., Sardão, V. A., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-68890-7 · Cited by 106 · cited 1×
“Estrogen exerts an anti-osteoporotic effect by inhibiting the activity of mitochondrial complex I in osteoclast progenitor cells to slow mitochondrial respiration and ATP generation and stimulate Bak/Bax-dependent mitochondrial apoptosis to reduce the number of osteoclasts (60).”
BackgroundZeng, R., Faccio, R., & Novack, D. V. (2015) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2584 · Cited by 105 · cited 1×
“Compared with monocyte precursors, mature osteoclasts contain larger mitochondria with more abundant cristae and considerable structural remodeling (48, 49).”
BackgroundMitochondrial Ca2+homeostasis in the regulation of apoptotic and necrotic cell deaths
Zhu, L. P., Yu, X. D., Ling, S. H., Brown, R., & Kuo, T. H. (2000) · Cell Calcium · doi:10.1054/ceca.2000.0138 · Cited by 101 · cited 1×
“When the homeostasis of the cytoplasmic calcium ion concentration is disturbed, cells generally undergo necrosis or apoptosis (68).”
BackgroundMurata, K., Fang, C., Terao, C., Γιαννοπούλου, Ε., Lee, Y. J., Lee, M. J., Mun, S. H., Bae, S., Qiao, Y., Yuan, R., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.06.018 · Cited by 101
Targeting autophagy in osteoporosis: From pathophysiology to potential therapy
Li, X., Xu, J., Dai, B., Wang, X., Guo, Q., & Qin, L. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101098 · Cited by 100
Feng, S., Deng, L., Chen, W., Shao, J., Xu, G., & Li, Y. (2008) · Biochemical Journal · doi:10.1042/bj20081073 · Cited by 99
Pereverzev, A., Komarova, S. V., Korčok, J., Armstrong, S., Tremblay, G. B., Dixon, S. J., & Sims, S. M. (2007) · Bone · doi:10.1016/j.bone.2007.08.044 · Cited by 98
Mitochondria: Potential Targets for Osteoarthritis
Mao, X., Fu, P., Wang, L., & Xiang, C. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.581402 · Cited by 98
Hygum, K., Starup‐Linde, J., & Langdahl, B. L. (2019) · Osteoporosis and Sarcopenia · doi:10.1016/j.afos.2019.05.001 · Cited by 95
Sitaraman, S. V., Wang, L., Wong, M., Bruewer, M., Hobert, M., Yun, C.-H., Merlin, D., & Madara, J. L. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202522200 · Cited by 93
Sirtuin 3 (SIRT3) maintains bone homeostasis by regulating AMPK-PGC-1β axis in mice
Huh, J.-E., Shin, J. H., Jang, E., Park, S. J., Park, D. R., Ko, R., Seo, D.-H., Kim, H. S., Lee, S. H., Choi, Y., et al. (2016) · Scientific Reports · doi:10.1038/srep22511 · Cited by 92
Kwak, H. B., Lee, B. K., Oh, J., Yeon, J., Choi, S., Cho, H. J., Lee, M. S., Kim, J.-J., Bae, J., Kim, S. H., et al. (2009) · Bone · doi:10.1016/j.bone.2009.10.042 · Cited by 89 · cited 1×
“The effect of OXPHOS on osteoclast formation can be further inhibited by the respiratory chain disruptor rotenone, thereby eliminating bone loss due to estrogen deficiency in mice (57, 58).”
BackgroundThe Roles of Acidosis in Osteoclast Biology
Yuan, F., Xu, M., Li, X., He, X.-L., Fang, W., & Dong, J. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00222 · Cited by 88
Morten, K. J., Badder, L., & Knowles, H. J. (2013) · The Journal of Pathology · doi:10.1002/path.4159 · Cited by 88 · cited 11×
“A hypoxia-induced factor-1 (HIF-1) active siRNA completely reversed the chronic (48 h) Frontiers in Endocrinology | www.frontiersin.org 6 hypoxic-exposure induced death of osteoclasts, with no effect on the activity of AMP-activated protein kinase (AMPK) (66).”
BackgroundInfluentialV-ATPases and osteoclasts: ambiguous future of V-ATPases inhibitors in osteoporosis
Duan, X., Yang, S., Zhang, L., & Yang, T. (2018) · Theranostics · doi:10.7150/thno.28391 · Cited by 86
Fatty acid metabolism by the osteoblast
Kushwaha, P., Wolfgang, M. J., & Riddle, R. C. (2017) · Bone · doi:10.1016/j.bone.2017.08.024 · Cited by 86
PPAR agonists modulate human osteoclast formation and activity in vitro
Chan, B. Y., Gartland, A., Wilson, P. J. M., Buckley, K. M., Dillon, J. P., Fraser, W. D., & Gallagher, J. A. (2006) · Bone · doi:10.1016/j.bone.2006.07.029 · Cited by 86
Energy metabolism: A newly emerging target of BMP signaling in bone homeostasis
Yang, J., Ueharu, H., & Mishina, Y. M. (2020) · Bone · doi:10.1016/j.bone.2020.115467 · Cited by 85
Oxidative Stress, Bone Marrow Failure, and Genome Instability in Hematopoietic Stem Cells
Richardson, C., Yan, S., & Vestal, C. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms16022366 · Cited by 81 · cited 1×
“Meanwhile, the production of oxygen free radicals in mitochondria is closely related to cellular signal transduction, transmembrane ion transport and electrolyte homeostasis (26, 27).”
BackgroundUnraveling the role of FoxOs in bone—Insights from mouse models
Almeida, M. (2011) · Bone · doi:10.1016/j.bone.2011.05.023 · Cited by 81
Chung, Y., Yoon, S., Choi, B., Sohn, D. H., Yoon, K.-H., Kim, W.-J., Kim, D., & Chang, E. (2012) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2012.03.007 · Cited by 79 · cited 1×
“This inhibitory effect enhances autophagy, which increases the bone resorption capacity by regulating actin and the microtubule network (75, 85); however, the inhibition of mTOR downregulates the expression of digestive enzymes and induces osteoclast apoptosis (86).”
BackgroundEnvironmental arginine controls multinuclear giant cell metabolism and formation
Brunner, J. S., Vulliard, L., Hofmann, M., Kieler, M., Lercher, A., Vogel, A., Russier, M., Brüggenthies, J. B., Kerndl, M., Saferding, V., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-14285-1 · Cited by 79 · cited 1×
“a-Ketoisocaproate, ketoisoleucine and phenylpyruvate also restore the inhibitory effect of the lack of parent amino acids on osteoclastogenesis (122).”
BackgroundKawashima, Y., Fritton, J. C., Yakar, S., Epstein, S., Schaffler, M. B., Jepsen, K. J., & LeRoith, D. (2008) · Bone · doi:10.1016/j.bone.2008.12.012 · Cited by 78
Su, Y., Elshorbagy, A. K., Turner, C., Refsum, H., Chan, R., & Kwok, T. C. Y. (2019) · Bone · doi:10.1016/j.bone.2019.115082 · Cited by 77
Hulley, P. A., Bishop, T., Vernet, A., Schneider, J. E., Edwards, J., Athanasou, N. A., & Knowles, H. J. (2017) · The Journal of Pathology · doi:10.1002/path.4906 · Cited by 77
Modulation of Bone and Marrow Niche by Cholesterol
Yin, W., Li, Z., & Zhang, W. (2019) · Nutrients · doi:10.3390/nu11061394 · Cited by 76
Zhang, J., Hu, W., Ding, C., Yao, G., Zhao, H., & Wu, S. (2019) · Toxicology Letters · doi:10.1016/j.toxlet.2019.06.007 · Cited by 76 · cited 1×
“The use of iron chelating agents reduces iron levels in osteoclasts and inhibits the enzymatic activities of mitochondrial complexes I, II and III, leading to a significant decrease in the ATP content and inhibition of the mitogenactivated protein kinase (MAPK) signaling pathway to restore bone mass (53).”
BackgroundATPase pumps in osteoclasts and osteoblasts
Francis, M. J. O., Lees, R. L., Trujillo, E., Martín-Vasallo, P., Heersche, J. N. M., & Mobasheri, A. (2002) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(01)00142-x · Cited by 74 · cited 1×
“Afterwards, mature osteoclasts adhere to the bone surface through avb integrin and form an F-actinsealed zone to absorb the bone matrix, while the acidic environment in the bone resorption region relies on carbonic anhydrase II to generate HCO and H, which passes through the folds of osteoclasts through vacuolar H ade…”
BackgroundZhou, T., Yang, Y., Chen, Q., & Xie, L. (2019) · Stem Cells International · doi:10.1155/2019/8928934 · Cited by 73 · cited 3×
“reported that hypoxia stimulates glutamine consumption by osteoclasts (66, 118).”
BackgroundChin, K., Wong, S. K., Ekeuku, S. O., & Pang, K.-L. (2020) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s275560 · Cited by 73
ASXL2 Regulates Glucose, Lipid, and Skeletal Homeostasis
Izawa, T., Rohatgi, N., Fukunaga, T., Wang, Q.-T., Silva, M. J., Gardner, M. J., McDaniel, M. L., Abumrad, N. A., Semenkovich, C. F., Teitelbaum, S. L., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.05.019 · Cited by 71 · cited 1×
“Compared with monocyte precursors, mature osteoclasts contain larger mitochondria with more abundant cristae and considerable structural remodeling (48, 49).”
BackgroundAccelerated Lactate Dehydrogenase Activity Potentiates Osteoclastogenesis via NFATc1 Signaling
Ahn, H., Lee, K., Kim, J., Kwon, S. H., Lee, S. H., Lee, S. Y., & Jeong, D. (2016) · PLoS ONE · doi:10.1371/journal.pone.0153886 · Cited by 69 · cited 1×
“found that RANKL-induced osteoclastogenesis was associated with increased activity of lactate dehydrogenase (LDH) to activate glycolysis, a process that relies on increased expression of proton-linked monocarboxylate transporters (MCT1, 2, 3, 5 and 8), excrete lactate from cells produced by increased glycolysis, reduc…”
BackgroundPatel, J. J., Butters, O., & Arnett, T. R. (2014) · Cell Biochemistry and Function · doi:10.1002/cbf.3025 · Cited by 67
Amino Acid Secondary Transporters
Schweikhard, E. S., & Ziegler, C. M. (2012) · Current topics in membranes · doi:10.1016/b978-0-12-394316-3.00001-6 · Cited by 63
Xue, L., Jiang, Y., Han, T., Zhang, N.-D., Qin, L., Xin, H., & Zhang, Q. (2016) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2016.07.037 · Cited by 63 · cited 2×
“Patients with a low bone mineral density and osteoporosis have higher lipid levels, and elevated serum levels of low/very low density lipoprotein (LDL/VLDL), glucose, lactate, and lipids have been detected in ovariectomized mice (42).”
BackgroundResultRegulation of bone and cartilage by adenosine signaling
Strazzulla, L. C., & Cronstein, B. N. (2016) · Purinergic Signalling · doi:10.1007/s11302-016-9527-2 · Cited by 60 · cited 1×
“Osteoblasts release a large amount of ATP through vesicle-mediated exocytosis, resulting in a significant increase in the extracellular concentration of adenosine during hypoxia or inflammation (100, 101).”
BackgroundLysosomal pH Plays a Key Role in Regulation of mTOR Activity in Osteoclasts
Hu, Y., Carraro‐Lacroix, L. R., Wang, A., Owen, C., Bajenova, E., Corey, P., Brumell, J. H., & Voronov, I. (2015) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25287 · Cited by 58 · cited 1×
“Lysosomes accumulate aciddegrading enzymes that are transported to the bone resorption region and constitute the main components of the bone resorption lacunae (77, 78).”
BackgroundFrom macrophage to osteoclast – How metabolism determines function and activity
Kubatzky, K. F., Uhle, F., & Eigenbrod, T. (2018) · Cytokine · doi:10.1016/j.cyto.2018.06.013 · Cited by 57 · cited 2×
“Osteoclasts reside in the resorption lacunae, where the oxygen tension is significantly lower than elsewhere in the hematopoietic chamber (64, 65).”
BackgroundDo polyunsaturated fatty acids protect against bone loss in our aging and osteoporotic population?
Martyniak, K., Wei, F., Ballesteros, A., Meckmongkol, T. T., Calder, A. N., Gilbertson, T. A., Orlovskaya, N. A., & Coathup, M. J. (2020) · Bone · doi:10.1016/j.bone.2020.115736 · Cited by 57
Cytokines and Hormones That Contribute to the Positive Association between Fat and Bone
Naot, D., & Cornish, J. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00070 · Cited by 57
Duan, X., Liu, J., Zheng, X., Wang, Z., Zhang, Y., Hao, Y., Yang, T., & Deng, H. (2016) · Theranostics · doi:10.7150/thno.17140 · Cited by 55
Anorexia Nervosa and Osteoporosis: Pathophysiology and Treatment
Steinman, J. R., & Shibli-Rahhal, A. A. (2019) · Journal of Bone Metabolism · doi:10.11005/jbm.2019.26.3.133 · Cited by 55
Motyl, K. J., Guntur, A. R., Carvalho, A., & Rosen, C. J. (2017) · Toxicologic Pathology · doi:10.1177/0192623317737065 · Cited by 55 · cited 2×
“It is used as an acetyl donor by histone acetyltransferase and is known to exist in two separate banks: one in the mitochondria and the other in the cytoplasm (90).”
BackgroundComparative study of protein and mRNA expression during osteoclastogenesis
Czupalla, C., Mansukoski, H., Pursche, T., Krause, E., & Hoflack, B. (2005) · PROTEOMICS · doi:10.1002/pmic.200402059 · Cited by 53 · cited 1×
“The energy required for osteoclast differentiation is mainly derived from mitochondrial oxidative metabolism (increased expression of OXPHOS enzymes, complexes I, II, III and V, electron transport chain subunits, intracellular ATP levels and a higher oxygen consumption rate) (89), while the activity of peripheral cell…”
BackgroundThioredoxin-1 mediates osteoclast stimulation by reactive oxygen species
Lean, J., Kirstein, B., Urry, Z., Chambers, T. J., & Fuller, K. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.07.035 · Cited by 52 · cited 1×
“The expression of thioredoxin-1 increases during osteoclast differentiation, which enhances the binding of the transcription factors AP-1, NF-kB and NFATc1 to their DNA recognition sites to support osteoclast differentiation (114, 115).”
BackgroundLi, M., Chen, X., Yan, J., Zhou, L., Wang, Y., He, F., Lin, J., Zhu, C., Pan, G., Yu, J., et al. (2018) · Acta Biomaterialia · doi:10.1016/j.actbio.2018.03.003 · Cited by 51
Miyamoto, T. K. (2015) · The Keio Journal of Medicine · doi:10.2302/kjm.2015-0003-re · Cited by 49
An, E., Narayanan, M., Manes, N. P., & Nita‐Lazar, A. (2014) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m113.034371 · Cited by 46 · cited 6×
“These data suggest that when OCs exceed a certain size and acquire too many nuclei, they also have too many mitochondrial copies, all of which can lead to cell death (37).”
BackgroundResultInfluentialAutophagic Regulation of Lipid Homeostasis in Cardiometabolic Syndrome
Yang, M., Zhang, Y., & Ren, J. T. (2018) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2018.00038 · Cited by 46 · cited 1×
“Autophagy also functions in lipid clearance (lipophagy) and plays an important role in lipid metabolism, lipoprotein assembly and lipid metabolism homeostasis (74).”
BackgroundBone: Another potential target to treat, prevent and predict diabetes
Liu, D., Mosialou, I., & Liu, J. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13330 · Cited by 46
Metabolomic Associations with Serum Bone Turnover Markers
Bellissimo, M. P., Roberts, J. L., Jones, D. P., Liu, K., Taibl, K. R., Uppal, K., Weitzmann, M. N., Pacifici, R., Drissi, H., Ziegler, T. R., et al. (2020) · Nutrients · doi:10.3390/nu12103161 · Cited by 46 · cited 1×
“Osteoclasts in the active bone resorption state show a high capacity for fatty acid b oxidation, suggesting that the high energy state of active osteoclasts may be mainly supported by lipid catabolism (127).”
BackgroundAitken, C. J., Hodge, J. M., Nishinaka, Y., Vaughan, T., Yodoi, J., Day, C. J., Morrison, N. A., & Nicholson, G. C. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.040913 · Cited by 45 · cited 1×
“The expression of thioredoxin-1 increases during osteoclast differentiation, which enhances the binding of the transcription factors AP-1, NF-kB and NFATc1 to their DNA recognition sites to support osteoclast differentiation (114, 115).”
BackgroundTong, X., Ganta, R. R., & Liu, Z. (2020) · Biology of the Cell · doi:10.1111/boc.202000008 · Cited by 44 · cited 1×
“Hypoxia alsoplays a major role in the regulation of mitochondrial autophagy and the subsequent release of reactive oxygen species (ROS) during osteoclast differentiation and functional activation (81).”
BackgroundOsteoporosis: A role for lipids
During, A. (2020) · Biochimie · doi:10.1016/j.biochi.2020.08.004 · Cited by 44
The Roles of Small GTPases in Osteoclast Biology
Oursler, M. J. (2014) · Orthopedic & Muscular System · doi:10.4172/2161-0533.1000161 · Cited by 43 · cited 1×
“Rac1/Rac2-deficient mice show an osteopetrotic phenotype despite a normal number of osteoclasts, indicating that the Rac protein is more important for bone resorption than differentiation in the body (111).”
BackgroundMatsumoto, T., Nagase, Y., Hirose, J., Tokuyama, N., Yasui, T., Kadono, Y., Ueki, K., Kadowaki, T., Nakamura, K., & Tanaka, S. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1844 · Cited by 43 · cited 1×
“In addition, the migration of osteoclasts along the bone surface contributes to the continuity of bone resorption, which is achieved through the dynamic rearrangement of the actin and microtubule cytoskeleton and requires excessive ATP consumption (29, 36).”
BackgroundFactors influencing bone loss in anorexia nervosa: assessment and therapeutic options
Legroux, I., & Cortet, B. (2019) · RMD Open · doi:10.1136/rmdopen-2019-001009 · Cited by 43
Zhao, S.-J., Kong, F., Cai, W. L., Xu, T., Zhou, Z., Wang, Z., Xu, A.-D., Yang, Y., Chen, J., Tang, P., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-1256-8 · Cited by 41 · cited 1×
“In addition, activated AMPK promotes osteoclast autophagy and increases osteoclast differentiation and bone resorption by inactivating mammalian target of rapamycin (mTOR) under lowenergy conditions, such as glucose or aminoaciddeficiency (82, 83).”
BackgroundKim, H., Kim, I. Y., Lee, S. Y., & Jeong, D. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.09.015 · Cited by 40 · cited 1×
“In conclusion, oxidative stress exerts a bimodal effect on osteoclasts: moderate stress promotes osteoclast formation, while severe stress inhibits osteoclast absorption and limits the lifetime of osteoclasts (116, 117).”
BackgroundDodds, R. A., Gowen, M., & Bradbeer, J. N. (1994) · Journal of Histochemistry & Cytochemistry · doi:10.1177/42.5.8157931 · Cited by 40
Secondary osteoporosis: thyrotoxicosis, rheumatoid arthritis, and diabetes mellitus
Inaba, M. (2004) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-004-0501-7 · Cited by 39
CRNDE impacts the proliferation of osteoclast by estrogen deficiency in postmenopausal osteoporosis.
Li, W., Hm, Z., Hd, X., ZHANG, B., & Sm, H. (2018) · PubMed · doi:10.26355/eurrev_201809_15907 · Cited by 36 · cited 1×
“Patients with osteoporosis express the long noncoding RNA (LncRNA) colorectal neoplasia differentially expressed (CRNDE) at high levels, and this LncRNA stimulates the proliferation of osteoclasts through the PI3K/Akt signaling pathway, a process that is inhibited by estrogen (59).”
BackgroundOh, S. J., Gu, D. R., Jin, S. H., Park, K. H., & Lee, S. H. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.05.055 · Cited by 36 · cited 3×
“Overall, cellular ATP levels reflect cellular viability, including cell survival, growth and morphology, and a relatively mild ATP loss appears to regulate cell differentiation, while excessive ATP consumption induces apoptosis, which ensures strong bone resorption (47).”
BackgroundInfluentialThyroid Hormone Actions and Bone Remodeling – The Role of the Wnt Signaling Pathway
Lademann, F., Tsourdi, E. A., Hofbauer, L. C., & Rauner, M. (2020) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-1088-1215 · Cited by 36
Bone density status in a large population of patients with anorexia nervosa
Workman, C., Blalock, D. V., & Mehler, P. S. (2019) · Bone · doi:10.1016/j.bone.2019.115161 · Cited by 34
Molecular Understanding of Osteoclast Differentiation and Physiology
Lee, N. K. (2010) · Endocrinology and Metabolism · doi:10.3803/enm.2010.25.4.264 · Cited by 33
Epigenetic Regulators Involved in Osteoclast Differentiation
Astleford, K., Campbell, E., Norton, A., & Mansky, K. C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197080 · Cited by 32
Mo, Y., Lai, W., Zhong, Y., Hu, Z., You, M., Du, M., Wang, P., Wu, X., Chen, C., He, H., et al. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118938 · Cited by 31
Moderate excess of pyruvate augments osteoclastogenesis
Fong, J. E., Nihouannen, D. L., Tiedemann, K., Sadvakassova, G., Barralet, J. E., & Komarova, S. V. (2013) · Biology Open · doi:10.1242/bio.20133269 · Cited by 30 · cited 2×
“org 10 metabolic disorders in the body are often accompanied by complications of osteoporosis, which are also based on the conversion of osteoclast energy metabolism (65, 91).”
BackgroundRyu, J., Kim, H., Chang, E., Kim, H. J., Lee, Y., & Kim, H. (2010) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-009-0150-y · Cited by 29
Role of Altered Metabolic Microenvironment in Osteolytic Metastasis
Tiedemann, K., Hussein, O., & Komarova, S. V. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00435 · Cited by 25
Kawahara, I., Koide, M., Tadokoro, O., Udagawa, N., Nakamura, H., Takahashi, N., & Ozawa, H. (2009) · Bone · doi:10.1016/j.bone.2009.07.010 · Cited by 21 · cited 1×
“The formation of mitochondrial granules depends on the direct transport of NaCa exchangers and the transport mediated by the endoplasmic reticulum, and these processes depend on the energy supplied by the respiratory chain (72).”
BackgroundThe Adenosine A2B Receptor Drives Osteoclast-Mediated Bone Resorption in Hypoxic Microenvironments
Knowles, H. J. (2019) · Cells · doi:10.3390/cells8060624 · Cited by 20
Vlaikou, A., Nußbaumer, M., Komini, C., Lambrianidou, A., Konidaris, C., Trangas, T. T., & Filiou, M. D. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.15057 · Cited by 14
Lu, Y., Lu, D., & Hu, Y. (2018) · Cell Proliferation · doi:10.1111/cpr.12443 · Cited by 12
Sun, Y., Hu, W., Yu, X., Liu, Z., Tarran, R., Ravid, K., & Huang, P. (2016) · Biochemical Journal · doi:10.1042/bcj20160272 · Cited by 12
Xiong, Q., Zhang, L., Zhan, S., Ge, W., & Tang, P. (2016) · Proteome Science · doi:10.1186/s12953-016-0097-6 · Cited by 10 · cited 3×
“In addition, some studies have found that osteoclasts cultured in low serum [1% fetal bovine serum (FBS)] exhibit a significant increase in the expression of proteins related to fatty acid oxidation, suggesting that fatty acid oxidation is involved in the formation of osteoclasts and the supply of ATP required for bon…”
BackgroundInfluentialMoro, L. (2020) · Biology · doi:10.3390/biology9120479 · Cited by 8
Hu, Z., Du, M., Lai, W., Liang, Y., Liu, Q., Mo, Y., Bei, J., Li, S., Yang, Y., Xu, J., et al. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000489187 · Cited by 7
Metadata
- Authors
- Da, W., Tao, L., & Zhu, Y.
- Venue
- Frontiers in Endocrinology
- Publisher
- Frontiers Media SA
- Published
- 2021-05-12
- Volume
- 12
- Pages
- 675385-675385
- ISSN
- 1664-2392 (ISSN-L)
- OpenAlex
- W3161309728
- Cited by
- 177
- References
- 170
- FWCI
- 6.78
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.